|
|
||||||||
B Activation1






*
Immune and Gene Therapy Laboratory, Department of Oncology and Pathology, Cancer Center Karolinska,
Center for Genomic Research, and
Microbiology and Tumorbiology Center, Karolinska Institute, Stockholm, Sweden; and
CALAB Research/NOVA Medical Flow Cytometry Laboratory, Stockholm, Sweden
Impaired immune responses in cancer patients have been associated
with oxidative stress. Increased levels of reactive oxygen species
released from activated, tumor-infiltrating macrophages or granulocytes
may therefore constitute a hurdle for effective immunotherapy against
cancer. In this study, we investigated functional consequences and
molecular events in T cells exposed to low levels of oxidative stress.
We observed that cytokine production of human PBMC, upon stimulation
with an HLA-A*0201-restricted influenza peptide and nonspecific
receptor cross-linking, was reduced after exposure to micromolar levels
of H2O2. Functional impairment as measured by
IFN-
release occurred earlier and at lower doses of exogenously
added H2O2 than required to induce apoptosis.
This suggests that there is a dose window of oxidative stress leading
to T cell unresponsiveness in the absence of apoptosis. The reduction
of Th1 cytokines, induced by H2O2, was
predominantly observed in memory/effector (CD45RO+) T cells
and correlated with a block in NF-
B activation. IL-10 production was
more profoundly influenced by low doses of H2O2
than IFN-
, TNF-
, and IL-2. The influence of
H2O2 on production of IL-10 was not
significantly different between memory/activated and naive T cells.
These observations suggest that Th1 and Th2 cytokines are differently
regulated under conditions of oxidative stress. Taken together, these
findings may explain why Ag-experienced, CD45RO+, T cells
found in the tumor milieu are functionally
suppressed.
This article has been cited by other articles:
![]() |
D. Mougiakakos, C. C. Johansson, and R. Kiessling Naturally occurring regulatory T cells show reduced sensitivity toward oxidative stress-induced cell death Blood, April 9, 2009; 113(15): 3542 - 3545. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ando, K. Mimura, C. C. Johansson, M. G. Hanson, D. Mougiakakos, C. Larsson, T. Martins da Palma, D. Sakurai, H. Norell, M. Li, et al. Transduction with the Antioxidant Enzyme Catalase Protects Human T Cells against Oxidative Stress J. Immunol., December 15, 2008; 181(12): 8382 - 8390. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nadeem, A. Masood, and N. Siddiqui Review: Oxidant--antioxidant imbalance in asthma: scientific evidence, epidemiological data and possible therapeutic options Therapeutic Advances in Respiratory Disease, August 1, 2008; 2(4): 215 - 235. [Abstract] [PDF] |
||||
![]() |
F. B. Thoren, A. I. Romero, S. Hermodsson, and K. Hellstrand The CD16-/CD56bright Subset of NK Cells Is Resistant to Oxidant-Induced Cell Death J. Immunol., July 15, 2007; 179(2): 781 - 785. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Boulland, J. Marquet, V. Molinier-Frenkel, P. Moller, C. Guiter, F. Lasoudris, C. Copie-Bergman, M. Baia, P. Gaulard, K. Leroy, et al. Human IL4I1 is a secreted L-phenylalanine oxidase expressed by mature dendritic cells that inhibits T-lymphocyte proliferation Blood, July 1, 2007; 110(1): 220 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bhattacharyya, D. Mandal, G. S. Sen, S. Pal, S. Banerjee, L. Lahiry, J. H. Finke, C. S. Tannenbaum, T. Das, and G. Sa Tumor-Induced Oxidative Stress Perturbs Nuclear Factor-{kappa}B Activity-Augmenting Tumor Necrosis Factor-{alpha}-Mediated T-Cell Death: Protection by Curcumin Cancer Res., January 1, 2007; 67(1): 362 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Takahashi, M. G. V. Hanson, H. R. Norell, A. M. Havelka, K. Kono, K.-J. Malmberg, and R. V. R. Kiessling Preferential Cell Death of CD8+ Effector Memory (CCR7-CD45RA-) T Cells by Hydrogen Peroxide-Induced Oxidative Stress J. Immunol., May 15, 2005; 174(10): 6080 - 6087. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Ichihara, K. Kono, A. Takahashi, H. Kawaida, H. Sugai, and H. Fujii Increased Populations of Regulatory T Cells in Peripheral Blood and Tumor-Infiltrating Lymphocytes in Patients with Gastric and Esophageal Cancers Clin. Cancer Res., October 1, 2003; 9(12): 4404 - 4408. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, R. A. Barke, R. Charboneau, H. H. Loh, and S. Roy Morphine Negatively Regulates Interferon-{gamma} Promoter Activity in Activated Murine T Cells through Two Distinct Cyclic AMP-dependent Pathways J. Biol. Chem., September 26, 2003; 278(39): 37622 - 37631. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Z. Rofael, R. M. Turkall, and M. S. Abdel-Rahman Effect of Ketamine on Cocaine-Induced Immunotoxicity in Rats International Journal of Toxicology, September 1, 2003; 22(5): 343 - 358. [Abstract] [PDF] |
||||
![]() |
K.-J. Malmberg, R. Lenkei, M. Petersson, T. Ohlum, F. Ichihara, B. Glimelius, J.-E. Frodin, G. Masucci, and R. Kiessling A Short-Term Dietary Supplementation of High Doses of Vitamin E Increases T Helper 1 Cytokine Production in Patients with Advanced Colorectal Cancer Clin. Cancer Res., June 1, 2002; 8(6): 1772 - 1778. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |